Explore Products

My Quote Request

No products added yet

6505-00-782-2086

20 Products

NDC00075-3510-06

THYROID TABLETS,USP

NSN, MFG P/N

6505007822086

NSN

6505-00-782-2086

View More Info

NDC00075-3510-06

THYROID TABLETS,USP

NSN, MFG P/N

6505007822086

NSN

6505-00-782-2086

MFG

USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS THYROID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00005-2054-25

POLIOVIRUS VACCINE LIVE ORAL,USP

NSN, MFG P/N

6505007822650

NSN

6505-00-782-2650

View More Info

NDC00005-2054-25

POLIOVIRUS VACCINE LIVE ORAL,USP

NSN, MFG P/N

6505007822650

NSN

6505-00-782-2650

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

IMMEDIATE CONTAINER QUANTITY: 1
IMMEDIATE CONTAINER TYPE: BOTTLE W/DROPPER
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10 DOSES
SPECIAL FEATURES: ORAL; LIVE; SABIN STRAINS TYPE 1,2,AND 3
UNIT PACKAGE QUANTITY: 1
UNIT PACKAGE TYPE: PACKAGE

570-26

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

View More Info

570-26

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

MFG

MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 30CC BT 3 PER PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USE PREFERRED JDF NSN 6505007679111
TOTAL PRIMARY CONTAINER QUANTITY: 3

MUCOMYST

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

View More Info

MUCOMYST

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

MFG

MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 30CC BT 3 PER PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USE PREFERRED JDF NSN 6505007679111
TOTAL PRIMARY CONTAINER QUANTITY: 3

MUCOMYST SOILUTION

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

View More Info

MUCOMYST SOILUTION

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

MFG

MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 30CC BT 3 PER PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USE PREFERRED JDF NSN 6505007679111
TOTAL PRIMARY CONTAINER QUANTITY: 3

NDC00054-3026-02

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

View More Info

NDC00054-3026-02

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 30CC BT 3 PER PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USE PREFERRED JDF NSN 6505007679111
TOTAL PRIMARY CONTAINER QUANTITY: 3

NDC00087-0570-09

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

View More Info

NDC00087-0570-09

ACETYLCYSTEINE SOLUTION,USP

NSN, MFG P/N

6505007822688

NSN

6505-00-782-2688

MFG

BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETYLCYSTEINE SOLUTION USP 20% 30CC BT 3 PER PG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USE PREFERRED JDF NSN 6505007679111
TOTAL PRIMARY CONTAINER QUANTITY: 3

GELUSIL

ALUMINUM HYDROXIDE GEL,DRIED,AND MAGNESIUM TRISILICATE TABLETS

NSN, MFG P/N

6505007823956

NSN

6505-00-782-3956

View More Info

GELUSIL

ALUMINUM HYDROXIDE GEL,DRIED,AND MAGNESIUM TRISILICATE TABLETS

NSN, MFG P/N

6505007823956

NSN

6505-00-782-3956

MFG

WARNER-CHILCOTT LABORATORIES DIV OF WARNER-LAMBERT PHARMACEUTICAL CO CUSTOMER SERVICE DEPT

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 GRAMS ALUMINUM HYDROXIDE GEL ACTIVE INGREDIENT AND 0.500 GRAMS MAGNESIUM TRISILICATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10

6-1353

GRISEOFULVIN TABLETS,USP

NSN, MFG P/N

6505007826510

NSN

6505-00-782-6510

View More Info

6-1353

GRISEOFULVIN TABLETS,USP

NSN, MFG P/N

6505007826510

NSN

6505-00-782-6510

MFG

DEFENSE MEDICAL STANDARDIZATION BOARD

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GRISEOFULVIN TABLETS USP 500MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

GRIFULVON V

GRISEOFULVIN TABLETS,USP

NSN, MFG P/N

6505007826510

NSN

6505-00-782-6510

View More Info

GRIFULVON V

GRISEOFULVIN TABLETS,USP

NSN, MFG P/N

6505007826510

NSN

6505-00-782-6510

MFG

ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GRISEOFULVIN TABLETS USP 500MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00062-0214-70

GRISEOFULVIN TABLETS,USP

NSN, MFG P/N

6505007826510

NSN

6505-00-782-6510

View More Info

NDC00062-0214-70

GRISEOFULVIN TABLETS,USP

NSN, MFG P/N

6505007826510

NSN

6505-00-782-6510

MFG

ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GRISEOFULVIN TABLETS USP 500MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00182-1609-37

TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDE SYRUP,USP

NSN, MFG P/N

6505007826761

NSN

6505-00-782-6761

View More Info

NDC00182-1609-37

TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDE SYRUP,USP

NSN, MFG P/N

6505007826761

NSN

6505-00-782-6761

MFG

GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 MILLIGRAMS TRIPROLIDINE HYDROCHLORIDE PER MILLILITER AND 6.000 MILLIGRAMS PSEUDOEPHEDRINE HYDROCHLORIDE PER MILLILITER
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIPROLIDINE AND PSEUDOEPHEDRINE HCL SYRUP USP 4FL OZ (118 ML)
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PALATABLE; TARTRAZINE-FREE; WITH SUITABLE PRESERVATIVES; W/CHILD PROOF CLOSURE

NDC00071-0237-24

ETHOSUXIMIDE CAPSULES,USP

NSN, MFG P/N

6505007826762

NSN

6505-00-782-6762

View More Info

NDC00071-0237-24

ETHOSUXIMIDE CAPSULES,USP

NSN, MFG P/N

6505007826762

NSN

6505-00-782-6762

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ETHOSUXIMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ETHOSUXIMIDE CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE

ZARONTIN CAPSULE

ETHOSUXIMIDE CAPSULES,USP

NSN, MFG P/N

6505007826762

NSN

6505-00-782-6762

View More Info

ZARONTIN CAPSULE

ETHOSUXIMIDE CAPSULES,USP

NSN, MFG P/N

6505007826762

NSN

6505-00-782-6762

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ETHOSUXIMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ETHOSUXIMIDE CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE

NDC00008-0325-01

CODEINE SULFATE TABLETS,USP

NSN, MFG P/N

6505007829573

NSN

6505-00-782-9573

View More Info

NDC00008-0325-01

CODEINE SULFATE TABLETS,USP

NSN, MFG P/N

6505007829573

NSN

6505-00-782-9573

MFG

AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS CODEINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE II
TOTAL PRIMARY CONTAINER QUANTITY: 1

NDC00031-7824-63

GLYCOPYRROLATE TABLETS,USP

NSN, MFG P/N

6505007830242

NSN

6505-00-783-0242

View More Info

NDC00031-7824-63

GLYCOPYRROLATE TABLETS,USP

NSN, MFG P/N

6505007830242

NSN

6505-00-783-0242

MFG

ROBINS A H CO INC GOVERNMENT SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS GLYCOPYRROLATE ACTIVE INGREDIENT
COATING FEATURE: COMPRESSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCOPYRROLATE TABLETS USP 1MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: NOTE: W/POTENCY PERIOD OR EXPIRATION DATE

NDC59630-0200-10

GLYCOPYRROLATE TABLETS,USP

NSN, MFG P/N

6505007830242

NSN

6505-00-783-0242

View More Info

NDC59630-0200-10

GLYCOPYRROLATE TABLETS,USP

NSN, MFG P/N

6505007830242

NSN

6505-00-783-0242

MFG

SHIONOGI PHARMA INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS GLYCOPYRROLATE ACTIVE INGREDIENT
COATING FEATURE: COMPRESSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCOPYRROLATE TABLETS USP 1MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: NOTE: W/POTENCY PERIOD OR EXPIRATION DATE

ROBINUL

GLYCOPYRROLATE TABLETS,USP

NSN, MFG P/N

6505007830242

NSN

6505-00-783-0242

View More Info

ROBINUL

GLYCOPYRROLATE TABLETS,USP

NSN, MFG P/N

6505007830242

NSN

6505-00-783-0242

MFG

ROBINS A H CO INC GOVERNMENT SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS GLYCOPYRROLATE ACTIVE INGREDIENT
COATING FEATURE: COMPRESSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLYCOPYRROLATE TABLETS USP 1MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: NOTE: W/POTENCY PERIOD OR EXPIRATION DATE

NDC00069-5440-93

HYDROXYZINE PAMOATE ORAL SUSPENSION,USP

NSN, MFG P/N

6505007836699

NSN

6505-00-783-6699

View More Info

NDC00069-5440-93

HYDROXYZINE PAMOATE ORAL SUSPENSION,USP

NSN, MFG P/N

6505007836699

NSN

6505-00-783-6699

MFG

PFIZER INC. DBA PFIZER

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HYDROXYZINE PAMOATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYZINE PAMOATE ORAL SUSP NF 1 PINT
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE

VISTARIL ORAL SUSPENSION

HYDROXYZINE PAMOATE ORAL SUSPENSION,USP

NSN, MFG P/N

6505007836699

NSN

6505-00-783-6699

View More Info

VISTARIL ORAL SUSPENSION

HYDROXYZINE PAMOATE ORAL SUSPENSION,USP

NSN, MFG P/N

6505007836699

NSN

6505-00-783-6699

MFG

PFIZER INC. DBA PFIZER

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HYDROXYZINE PAMOATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYZINE PAMOATE ORAL SUSP NF 1 PINT
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE